论文部分内容阅读
对１９８８年７月１９９４年８月间接受放疗的６７例晚期口腔颌面部鳞癌术后复发患者进行评价。结果：放疗后完全缓解为２９．９％（２０／６７），部分缓解为４０．３％（２７／６７），无效为２９．９％（２０／６７）；总有效率为７０．１％（４７／６７）；放疗后已死亡５０例，中位生存期１６月；生存率：１年为５６．７％（３８／６７），２年为２０．９％（１４／６７），３年为４．５％（３／６７）；远处转移率３１．３％，放疗并发症率１１．９％。分析表明，照射５０Ｇｙ以上患者的疗效显著优于５０Ｇｙ以下者（Ｐ＜０．０１）；超分割连续放射的疗效优于分段放射（Ｐ＜０．０５）。本文对复发患者的放疗反指证及提高疗效的多模式治疗进行了讨论。
The 67 patients with advanced oral and maxillofacial squamous cell carcinoma who received radiotherapy between July 1988 and August 1994 were evaluated. Results: The complete remission after radiotherapy was 29.9% (20/67), partial remission was 40.3% (27/67), and the invalidity was 29.9% (20/67); the total effective rate was 70.1% (47/67); 50 cases died after radiotherapy and the median survival period was 16 months; the survival rate was 56.7% (38/67) in 1 year and 20.9% (14/67) in 2 years, 3 The annual rate was 4.5% (3/67); the distant metastasis rate was 31.3%, and the radiotherapy complication rate was 11.9%. The analysis showed that the effect of patients with 50Gy or above was significantly better than those with 50Gy or less (P<0.01); the effect of hyperfractionated continuous radiation was superior to segmented radiation (P<0.05). This article discusses the recurrence of patients with radiotherapy anti-indication and multimodal therapy to improve efficacy.